Results 201 to 210 of about 13,589 (222)

Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain

Fertility and Sterility, 2006
Sandra Ann Carson
exaly  

Release of Medroxyprogesterone Acetate from a Silicone Polymer

Journal of Pharmaceutical Sciences, 1970
W I Higuchi, W I Higuchi, T J Roseman
exaly  

Medroxyprogesterone Acetate

2011
openaire   +1 more source

MEDROXYPROGESTERONE ACETATE AND HOMOZYGOUS SICKLE-CELL DISEASE

Lancet, The, 1982
Richard Hayes
exaly  

Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate

Fertility and Sterility, 2006
Barcey Levy, M Kathleen Clark, Maryfran Sowers   +2 more
exaly  

Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone

American Journal of Obstetrics and Gynecology, 1994
J Donald Woodruff, James H Pickar, J H Pickar   +2 more
exaly  

Medroxyprogesterone Acetate

2016
openaire   +1 more source

Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate

Contraception, 2014
Carolyn Westhoff, Katharine White
exaly  

Implanon® versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis — a pilot study

Contraception, 2009
Christine Kurz, Elisabeth Pernicka, Katharina Walch   +2 more
exaly  

Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy

Fertility and Sterility, 2008
Eliana Amaral, Luis Bahamondes, Kavita Nanda   +2 more
exaly